Nanotechnology and tumor imaging: Seizing an opportunity

Molecular Imaging

Volumn 3, Issue 4, 2004, Pages 364-369

  Sullivan, Daniel C ^a   Ferrari, Mauro ^a,b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Cancer; Early detection; Molecular imaging; Nanotechnology; Noninvasive

Indexed keywords

EARLY DETECTION; MOLECULAR IMAGING; NANOPARTICLES; NONINVASIVE;

COMPUTERIZED TOMOGRAPHY; DIAGNOSIS; ENZYMES; MACROMOLECULES; MAGNETIC RESONANCE IMAGING; NANOTECHNOLOGY; ONCOLOGY; POSITRON EMISSION TOMOGRAPHY; RADIOISOTOPES; RARE EARTH ELEMENTS; SUPRAMOLECULAR CHEMISTRY; TUMORS;

MEDICAL IMAGING;

NANOMATERIAL;

HEALTH CARE ORGANIZATION; HUMAN; NANOTECHNOLOGY; NEOPLASM; ONCOLOGY; REVIEW; UNITED STATES;

HUMANS; MEDICAL ONCOLOGY; NANOSTRUCTURES; NANOTECHNOLOGY; NATIONAL INSTITUTES OF HEALTH (U.S.); NEOPLASMS; UNITED STATES;

EID: 13844276739     PISSN: 15353508     EISSN: None     Source Type: Journal    
DOI: 10.1162/1535350042973526     Document Type: Review

References (25)

1. Li KC, Guccione S, Bednarski MD (2002). Combined vascular targeted imaging and therapy: A paradigm for personalized treatment. J Cell Biochem Suppl. 39:65-71.
2. Harisinghani MG, Barentsz J, Hahn PF, Deserno WM, Tabatabaei S, van de Kaa CH, de la Rosette J, Weissleder R (2003). Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med. 348:2491-2499.
3. Kobayashi H, Kawamoto S, Sakai Y, Choyke PL, Star RA, Brechbiel MW, Sato N, Tagaya Y, Morris JC, Waldmann TA (2004). Lymphatic drainage imaging of breast cancer in mice by micromagnetic resonance lymphangiography using a nano-size paramagnetic contrast agent. J Natl Cancer Inst. 96:703-708.
4. Sokolov K, Aaron J, Hsu B, Nida D, Gillenwater A, Follen M, MacAulay C, Adler-Storthz K, Korgel B, Descour M, Pasqualini R, Arap W, Lam W, Richards-Kortum R (2003). Optical systems for in vivo molecular imaging of cancer. Technol Cancer Res Treat. 2:491-504.
5. Choy G, Choyke P, Libutti SK (2003). Current advances in molecular imaging: Noninvasive in vivo bioluminescent and fluorescent optical Imaging in cancer research. Mol Imaging. 2:303-312.
6. Sokolov K, Sung KB, Collier T, Clark A, Arifler D, Lacy A, Descour M, Richards-Kortum R (2002). Endoscopic microscopy. Dis Markers. 18:269-291.
7. Hirsch LR, Stafford RJ, Bankankson JA, Sershen SR, Rivera B, Price RE, Hazle JD, Halas NJ, West JL (2003). Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance. Proc Natl Acad Sci USA. 100:13549-13554.
8. O'Neal DP, Hirsch LR, Halas NJ, Payne JD, West JL (2004). Photothermal tumor ablation in mice using near infrared-absorbing nanoparticles. Cancer Lett. 209:171-176.
9. Hanahan D, Weinberg RA (2000). The hallmarks of cancer. Cell. 100:57-70.
10. Brasch RC, Li KC, Husband JE, Keogan MT, Neeman M, Padhani AR, Shames D, Turetschek K (2000). In vivo monitoring of tumor angiogenesis with MR imaging. Acad Radiol. 7:812-823.
11. Sipkins DA, Cheresh DA, Kazemi MR, Nevin LM, Bednarski MD, Li KC (1998). Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging. Nat Med. 4:623-626.
12. Kircher MF, Allport JR, Graves EE, Love V, Josephson L, Lichtman AH, Weissleder R (2003). In vivo high resolution three-dimensional imaging of antigen-specific cytotoxic T-lymphocyte trafficking to tumors. Cancer Res. 63:6939-6946.
13. Anderson SA, Rader RK, Westlin WF, Null C, Jackson D, Lanza GM, Wickline SA, Kotyk JJ (2000). Magnetic resonance contrast enhancement of neovasculature with alpha(v)beta(3)-targeted nanoparticles. Magn Reson Med. 44:433-439.
14. Ferrara KW, Merritt CR, Burns PN, Foster FS, Mattrey RF, Wickline SA (2000). Evaluation of tumor angiogenesis with U.S.A.: Imaging, Doppler, and contrast agents. Acad Radiol. 7:824-839.
15. Fadeel B (2004). Plasma membrane alterations during apoptosis: Role in corpse clearance. Antioxid Redox Signal. 6:269-275.
16. Schellenberger EA, Bogdanov A Jr, Hogemann D, Tait J, Weissleder R, Josephson L (2002). Annexin V-CLIO: A nanoparticle for detecting apoptosis by MRI. Mol. Imaging. 1:102-107.
17. Amirghofran Z, Monabati A, Gholijani N (2004). Androgen receptor expression in relation to apoptosis and the expression of cell cycle related proteins in prostate cancer. Pathol Oncol Res. 10:37-41.
18. Groeger AM, Esposito V, De Luca A, Cassandro R, Tonini G, Ambrogi V, Baldi F, Goldfarb R, Mineo TC, Baldi A, Wolner E (2004). Prognostic value of immunohistochemical expression of p53, bax, Bcl-2 and Bcl-xL in resected non-small-cell lung cancers. Histopathology. 44:54-63.
19. Pollard RE, Sadlowski AR, Bloch SH, Murray L, Wisner ER, Griffey S, Ferrara KW (2002). Contrast-assisted destruction-replenishment ultrasound for the assessment of tumor microvasculature in a rat model. Technol Cancer Res Treat. 1:459-470.
20. Winter PM, Caruthers SD, Kassner A, Harris TD, Chinen LK, Allen JS, Lacy EK, Zhang H, Robertson JD, Wickline SA, Lanza GM (2003). Molecular imaging of angiogenesis in nascent Vx-2 rabbit tumors using a novel alpha(nu)beta3-targeted nanoparticle and 1.5 tesla magnetic resonance imaging. Cancer Res. 63:5838-5843.
21. Black P (1988). Management of malignant glioma: Role of surgery in relation to multimodal therapy. J Neurovirol. 4:227-236.
22. Lin WC, Toms SA, Johnson M, Jansen ED, Mahadevan-Jansen A (2001). In vivo brain tumor demarcation using optical spectroscopy. Photochem Pbotobiol. 73:396-402.
23. Zimmermann M, Seifert V, Trantakis C, Raabe A (2001). Open MRI-guided microsurgery of intracranial tumours in or near eloquent brain areas. Acta Neurochir (Wien). 143:327-337.
24. Kircher MF, Mahmood U, King RS, Weissleder R, Josephson L (2003). A multimodal nanoparticle for preoperative magnetic resonance imaging and intraoperative optical brain tumor delineation. Cancer Res. 63:8122-8125.
25. National Institutes of Health. Catalyzing Team Science: Report from the 2003 BECON Symposium. http://www.becon2.nih.gov/symposia_2003/ becon2003_symposium_final.pdf.